+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prevalence of cardiovascular and metabolic events in patients prescribed clozapine: a retrospective observational, clinical cohort study

Prevalence of cardiovascular and metabolic events in patients prescribed clozapine: a retrospective observational, clinical cohort study

Current Drug Safety 10(2): 125-131

The efficacy of clozapine for the treatment of schizophrenia has been demonstrated. However, a range of adverse events have been associated with its use. To date, there remains a paucity of data regarding the prevalence of clozapine-induced cardiovascular (CV) and parameters associated with the development of metabolic syndrome, alongside associated risk factors for their development. An observational, clinical cohort study design of 355 clozapine patients who were enrolled in the Barwon Health Clozapine Program at Geelong Hospital, Victoria, Australia, between 2008-12. Medical records were accessed retrospectively. Multivariate logistic regression was used to determine associations with adverse event(s). Older age of commencement with clozapine was consistently associated with increased risk of CV abnormalities, with the exception of tachycardia where older age was protective (Odds Ratio [OR]: 0.97; 95% Confidence Intervals [CI]: 0.95, 0.99). Males had significantly greater odds of most metabolic disturbances with the exception of being obese (BMI: ≥30 OR: 0.45; 95% CIs: 0.24, 0.85). Older age of commencement was a significantly associated variable with High- Density Lipoprotein-cholesterol (OR: 1.03; 95% CIs: 1.01, 1.07) and fasting glucose (OR:1.04; 95% CIs: 1.02, 1.07). An increase in BMI was consistently and significantly associated with all metabolic events. Male patients who are obese at any point during treatment and older at treatment commencement may be the most vulnerable to adverse CV and metabolic events. While future studies using a matched case-control design may be required to verify these findings, we recommend that treating clinicians consider these risks when assessing patient suitability to clozapine therapy.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 058617477

Download citation: RISBibTeXText

PMID: 25986036

Related references

Comparison of incidences of cardiovascular events among new users of different statins: a retrospective observational cohort study. Current Medical Research and Opinion 25(11): 2621-2629, 2009

Clinical and economic burden associated with cardiovascular events among patients with hyperlipidemia: a retrospective cohort study. Bmc Cardiovascular Disorders 16: 13, 2016

Effect of adding GLP-1RA on mortality, cardiovascular events, and metabolic outcomes among insulin-treated patients with type 2 diabetes: A large retrospective UK cohort study. American Heart Journal 196: 18-27, 2018

Risk of cardiovascular events, arrhythmia and all-cause mortality associated with clarithromycin versus alternative antibiotics prescribed for respiratory tract infections: a retrospective cohort study. Bmj Open 7(1): E013398, 2017

Metabolic Acidosis 1 Year Following Kidney Transplantation and Subsequent Cardiovascular Events and Mortality: An Observational Cohort Study. American Journal of Kidney Diseases 2019, 2019

Prevalence and associations of the metabolic syndrome among patients prescribed clozapine. Irish Journal of Medical Science 177(3): 205-210, 2008

Cardiovascular Disease Mortality in Patients With Chronic Schizophrenia Treated With Clozapine: A Retrospective Cohort Study. Yearbook of Psychiatry and Applied Mental Health 2011: 333-335, 2011

Cardiovascular disease mortality in patients with chronic schizophrenia treated with clozapine: a retrospective cohort study. Journal of Clinical Psychiatry 71(3): 304-311, 2010

Rate of serious infection in patients who are prescribed systemic biologic or nonbiologic agents for psoriasis: A large, single center, retrospective, observational cohort study. Dermatologic Therapy 30(5), 2017

Impact of diabetes duration and degree of carotid artery stenosis on major adverse cardiovascular events: a single-center, retrospective, observational cohort study. Cardiovascular Diabetology 16(1): 74, 2018

Prevalence of baseline lipid monitoring in patients prescribed second-generation antipsychotics during their index hospitalization: a retrospective cohort study. General Hospital Psychiatry 34(4): 380-384, 2012

Readmissions Following a Hospitalization for Cardiovascular Events in Dialysis Patients: A Retrospective Cohort Study. Journal of the American Heart Association 7(4), 2018

ANRIL as a genetic marker for cardiovascular events in renal transplant patients - an observational follow-up cohort study. Transplant International 2018, 2018

Risk of Hospitalization for Cardiovascular Events with β-Blockers in Hypertensive Patients: A Retrospective Cohort Study. Cardiology and Therapy 7(2): 173-183, 2018

Bisphosphonate therapy, death, and cardiovascular events among female patients with CKD: a retrospective cohort study. American Journal of Kidney Diseases 59(5): 636-644, 2012